Background: We have reported that prenatal alcohol exposure (PAE)-induced deficits in dentate gyrus, long-term potentiation (LTP), and memory are ameliorated by the histamine H 3 receptor inverse agonist ABT-239. Curiously, ABT-239 did not enhance LTP or memory in control offspring. Here, we initiated an investigation of how PAE alters histaminergic neurotransmission in the dentate gyrus and other brain regions employing combined radiohistochemical and electrophysiological approaches in vitro to examine histamine H 3 receptor number and function.
I
T IS WELL established that drinking during pregnancy can cause long-term neurobehavioral impairments in affected offspring (see review by Kodituwakku, 2009) . Children with fetal alcohol spectrum disorders (FASD) exhibit a broad range of cognitive difficulties and behavioral-emotional problems (Mattson et al., 2013) . Further, preclinical studies over the past 35 years have confirmed that prenatal or early postnatal exposure to alcohol produces a variety of behavioral deficits in affected offspring including behaviors homologous to behaviors altered in patients with FASD (for reviews, Kelley et al., 2009; Patton et al., 2014; Riley, 1990; Schneider et al., 2011) . Some of these behavioral deficits have been associated with functional damage to specific areas of the brain, such as the hippocampal formation, a brain region that appears to be particularly sensitive to perinatal ethanol exposure (Brady et al., 2012; Miki et al., 2008; Perrone-Bizzozero et al., 1998; Samudio-Ruiz et al., 2009; Sutherland et al., 1997; Titterness and Christie, 2012) . While multiple neurotransmitter systems are affected by exposure to alcohol during development (see review by Valenzuela et al., 2012) , efforts to link these prenatal alcohol exposure (PAE)-induced neurochemical alterations with specific functional and behavioral changes in PAE offspring have been limited.
We have reported subtle PAE-induced memory deficits in adult rat offspring whose mothers consumed moderate quantities of ethanol during pregnancy . Analogous to patients with FASD, these deficits become more apparent with more challenging behavioral tasks (Savage et al., 2002; Sutherland et al., 2000; Weeber et al., 2001) . "Baseline" physiological responses appear to be intact in our PAE rats while more complex, activity-dependent changes in synaptic plasticity are more sensitive to PAE (Costa et al., 2000; Savage et al., 1998; Sutherland et al., 1997) . A series of combined neurochemical and physiological studies provided evidence suggesting that presynaptic mechanisms associated with activity-dependent increases in glutamate release from perforant path terminals in dentate gyrus are 1 mechanism contributing to the long-term potentiation (LTP) deficits observed in our PAE rat offspring (Galindo et al., 2004; Perrone-Bizzozero et al., 1998; Savage et al., 1998 Savage et al., , 2002 .
Collectively, these observations led us to search for agents that target presynaptic mechanisms regulating neurotransmitter release, which might ameliorate PAE-induced deficits in synaptic plasticity and learning. Agents acting as antagonists or inverse agonists at histamine H 3 receptors are 1 candidate receptor mechanism. These drugs act by blocking a presynaptic histamine H 3 receptor-mediated inhibition of the release of a variety of neurotransmitters including histamine (Arrang et al., 1983) , other monoamines (Schlicker et al., 1988 (Schlicker et al., , 1989 (Schlicker et al., , 1993 , and acetylcholine (Clapham and Kilpatrick, 1992) . While activation of H 3 receptors also inhibits glutamate release (Brown and Haas, 1999; Garduno-Torres et al., 2007) , the question of whether H 3 receptor inverse agonists or antagonists can enhance glutamate release under basal or activity-dependent conditions has yet to be demonstrated. Collectively, more than a dozen H 3 receptor antagonists or inverse agonists have been shown to have procognitive effects in a variety of animal models of learning and memory (see reviews by Brioni et al., 2011; Esbenshade et al., 2008; Haas et al., 2008; Nikolic et al., 2014) .
Initial studies in our laboratory revealed that the H 3 receptor inverse agonist ABT-239 reverses PAE-induced deficits in LTP and learning . Curiously, ABT-239 did not enhance either LTP or learning in control offspring. Further, treatment of control offspring with the selective H 3 receptor agonist methimepip (Kitbunnadaj et al., 2005) mimicked the in vivo LTP deficit observed in saline-treated PAE rat offspring (Varaschin et al., 2014) . Taking these observations together, we hypothesized that PAE elevates histamine H 3 receptor-mediated inhibition of excitatory neurotransmission in the dentate gyrus. In an effort to begin investigating the mechanistic basis for the effects of PAE on histaminergic neurotransmission, we measured the number and function of H 3 receptors using a combination of radiohistochemical studies in various brain regions in conjunction with in vitro electrophysiological recordings in the same specific region of the dorsal dentate gyrus where we conducted in vivo electrophysiological recordings previously (Varaschin et al., , 2014 . We speculated that PAE elevates H 3 receptor density in the dentate gyrus leading to heightened H 3 receptor-mediated inhibition of excitatory transmission at the performant pathdentate granule cell synapse. 
MATERIALS AND METHODS

Reagents
Voluntary Drinking Paradigm
All procedures involving the use of live rats were approved by the University of New Mexico Health Sciences Center Institutional Animal Care and Use Committee. Long-Evans rats (Harlan Industries, Indianapolis, IN) housed at 22°C on a reverse 12-hour dark/12-hour light schedule (lights on from 2100 to 0900 hours) and provided Harlan 2920 rodent chow and tap water ad libitum. The PAE and breeding procedures were the same as described previously . After 1 week of acclimation to the animal facility, all female breeders were single-housed and allowed to drink 5% ethanol in 0.066% saccharin in tap water for 4 hours each day from 1000 to 1400 hours. Daily 4-hour ethanol consumption was monitored for at least 2 weeks, and then, the mean daily ethanol consumption was determined for each female. Females whose mean daily ethanol consumption was greater than 1 standard deviation below the group mean, typically about 12 to 15% of the entire group, were removed from the study. The remainder of the females were assigned to either a saccharin control or 5% ethanol drinking group and matched such that the mean prepregnancy ethanol consumption by each group was similar. Subsequently, females were placed with proven male breeders until pregnant, as indicated by the presence of a vaginal plug.
Beginning on gestational day 1 (GD1), rat dams were provided saccharin water containing either 0% or 5% ethanol for 4 hours each day, from 1000 to 1400 hours. The volume of saccharin water provided to the control group was matched to the mean volume of saccharin water consumed by the ethanol group. Daily 4-hour ethanol consumption was recorded for each dam through GD21, after which ethanol consumption was discontinued.
At birth, litters were culled to 10 pups each. Offspring were weaned at 24 days of age and group-housed, 2 males or 3 females per cage until experimental use. Female offspring were used in all of the histochemical and biochemical procedures, and male offspring were used in all of the electrophysiological procedures.
Serum Ethanol Assessment
Separate sets of 12 rat dams were used during 2 of the breeding rounds to assess the peak serum ethanol concentration. These dams were subjected to the same voluntary drinking paradigm as described above except that on GDs 13, 15, and 17, each dam was briefly anesthetized with isoflurane and a 100 ll blood sample was drawn from the tail vein 45 minutes after the introduction of the drinking tubes. The serum separated and the samples assayed for ethanol using a modification of the Lundquist assay (Lundquist, 1959) . No offspring from the dams used in the serum ethanol assessment were used in the experimental procedures described below.
Histological Sectioning
Eight-to twelve-week-old offspring were sacrificed by rapid decapitation. Whole brains were dissected, frozen in isopentane chilled in a dry ice/methanol bath, and stored in airtight containers at À80°C until sectioning. Twelve-micrometer-thick microtome cryostat sections were collected in the sagittal plane corresponding to lateral 1.40 mm in the Paxinos and Watson stereotaxic atlas of rat brain (Paxinos and Watson, 1998) . This plane contained the same region of the superior blade of the dorsal dentate gyrus where recordings were made in the in vitro electrophysiological studies described below, as well as our previous in vivo electrophysiological studies (Varaschin et al., , 2014 (Fig. 1 ) was conducted in a separate set of untreated control rats. Separate sets of control and PAE offspring were used for the (i) "2-point" saturation of [ 3 H]-A349821 binding study (see Table 2 ), (ii) brain region survey of methimepip-stimulated [ 35 S]-GTPcS binding ( Fig. 2A,B) , and (iii) a more detailed methimepip dose-response study (see Table 3 ; Fig. 3 ).
Specific [ 3 H]-A349821 Binding to Histamine H 3 Receptors
Histamine H 3 receptor density measures were performed using methods similar to those described by Witte and colleagues (2006 
S]-GTPcS Binding
Histamine H 3 agonist-stimulated receptor-effector coupling was performed using methods originally described by Sim and colleagues (1995) . Tissue sections were preincubated for 10 minutes in incubation buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl 2 , 0.2 mM EGTA, 2 mM GDP, and 100 nM DPCPX; pH 7.4 at 25°C) and then incubated with 100 pM [ 35 S]-GTPcS (Perkin Elmer, Shelton, CT; specific activity = 1,250 Ci/mmole) for 90 minutes at 25°C in the absence and presence or 10 lM unlabeled GTPcS. In addition, sections were incubated with 2 lM methimepip in an initial study to obtain measures of H 3 receptor agonist-stimulated [ 35 S]-GTPcS binding. In a subsequent more detailed concentrationresponse study, sections were incubated with 1 of 15 different concentrations of methimepip ranging from 0.1 nM to 5 lM. After incubation, sections were rinsed twice for 15 seconds each in icecold incubation buffer, dipped in ice-cold distilled water, dried, and placed in a vacuum desiccator overnight. Sections were then exposed to Kodak Biomax MR Film for 4 days, and then, the film was developed in Kodak D-19 (1:1) and fixed. Microdensitometric measurements of [ 
Extracellular Slice Recording Procedures
Eight-week-old rat offspring were deeply anesthetized with ketamine (250 mg/kg, intraperitoneally), quickly decapitated, and the brains removed. Coronal slices containing the dorsal dentate gyrus were obtained as described previously (Mameli et al., 2005) . Briefly, whole brain coronal slices (400 lm thick) were obtained using a vibrating microtome immersed in ice-cold cutting solution containing 3 mM KCl, 1.25 mM NaH 2 PO 4 , 6 mM MgSO 4 , 26 mM NaHCO 3 , 0.2 mM CaCl 2 , 10 mM glucose, 220 mM sucrose, and 0.43 mM ketamine. Slices were then allowed to recover for 40 minutes at 32°C in artificial cerebral-spinal fluid (ACSF) containing 126 mM NaCl, 2 mM KCl, 1.25 mM NaH 2 PO 4 , 1 mM MgSO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 , and 10 mM glucose and oxygenated with 95% O 2 /5% CO 2 . After recovery, slices were maintained in oxygenated ACSF at room temperature until recording. Upon transfer to recording chambers, slices were perfused at a rate of 2 ml/min with 32°C oxygenated ACSF containing different treatment conditions. Next, a concentric bipolar electrode (FHC, Bowdoin, ME) was placed in the medial portion of the superior blade of the dentate gyrus stratum moleculare, and a recording glass electrode (resistance~3 to 5 Ω) filled with ACSF placed in the same layer, about 200 lm lateral to the stimulating electrode. Electrically evoked field excitatory postsynaptic potentials (fEPSPs) were triggered using a Master-8 stimulator and an Iso-flex stimulus isolator (AMPI, Jerusalem, Israel) and recorded using a Digitizer model 1440 and AxoPatch 200 amplifier (Molecular Devices, Sunnyvale, CA) with low-pass filter set at 2 kHz.
Input/output curves were generated using a stimulus intensity range of 0.05 to 1.2 mA to determine the stimulus intensity sufficient to elicit maximal fEPSP amplitude. All subsequent recordings were performed with a test stimulus intensity sufficient to elicit 40% of the maximal fEPSP response (ES 40 ). A paired-pulse stimulation of the medial perforant path protocol, consisting of 2 pulses of 75 ls duration and 40 ms apart, was used. Pulses were delivered every 30 seconds over 10 minutes to establish a baseline response. Slices were then incubated for 10 minutes with 1 of 3 concentrations of methimepip (0.3, 1.0, or 3.0 lM). First-pulse fEPSP data obtained over the last 4 minutes during each drug treatment condition was averaged as a single measure and normalized to the baseline fEPSP amplitude. Paired-pulse ratio (PPR) was measured as the ratio of the fEPSP amplitude elicited by the second pulse divided by the fEPSP amplitude elicited by the first pulse and averaged as a single value over the last 4 minutes of each treatment condition.
Study Design Issues and Statistical Analyses
For each type of study, no more than 1 offspring per litter was used in a given experiment to avoid the prospect of "litter effects." Sample size determinations for these experiments indicated a minimum of n = 6, based on past receptor binding studies and in vitro slice electrophysiological studies in our laboratories with an minimum expected difference in group means of 20%, an expected standard deviation of 10%, and a desired power of 0.8 at an alpha value of 0.05. Seven or 8 pairs of subjects were used in all of the studies. There were no exclusion criteria, and no data were excluded from the analyses. All microdensitometric measurements and slice incubations, except the electrophysiological recordings, were performed by investigators blinded to the prenatal treatment condition of the samples, and samples were analyzed randomly in pairs. Although the investigator was not blinded to treatment in the slice electrophysiology studies, the only a priori rejection criterion used in the study was the stability of the baseline fEPSP amplitude (a maximum of 20% drift was acceptable) and no slice met that criterion. Bias on the PPR and on the effect of methimepip on the EPSP amplitude is minimal because no decision to include/exclude data points was made after bath application of the drug.
All statistical procedures and graphical illustrations were performed using SigmaPlot Ò 11 (Systat Software Inc., San Jose, CA). The effects of PAE on maternal weight gain, litter size, and offspring birthweight (Table 1) (Fig. 3) , input/output responses (Fig. 4) and methimepip effects on first-pulse fEPSPs and PPRs (Fig. 5) were analyzed using a repeated measures 2-way ANOVAs. Post hoc pairwise multiple comparisons were made using the Student-NewmanKeuls method. All data are expressed as the mean AE standard error of the mean (SEM), and a value of p < 0.05 was deemed as statistically significant.
RESULTS
Voluntary Drinking Paradigm
Rat dams consumed an average of 1.98 AE 0.07 g/kg/d of ethanol throughout gestation, a level of consumption that produced a mean serum ethanol concentration of 60.8 + 5.8 mg/dl (Table 1) 45 minutes after the introduction of the drinking tubes, 30 minutes after the observed mean peak ethanol consumption time at 15 minutes (data not shown). This voluntary drinking paradigm did not affect maternal weight gain, litter size, or offspring birthweight (Table 1) .
Histamine H 3 Receptor Binding Studies
We first characterized specific [ 3 H]-A349821 binding to sagittal brain sections from untreated control rats. A349821 is a histamine H 3 receptor antagonist that binds with similar affinity to H 3 receptor isoforms (Witte et al., 2006) . Figure 1A illustrates the distribution of total [ 3 H]-A349821 binding to histamine H 3 receptors in a sagittal section from an untreated rat brain. Histamine H 3 receptors exist in relatively low densities throughout the rat brain. Thus, extended periods of film exposure (4 months) are required, due to the low receptor density coupled with the use of a tritiated radioligand. A longer exposure period increases the film background measure leading to a corresponding reduction in the signal-to-noise ratio and limiting the number of discreet brain regions where we could reproducibly quantitate with relatively higher densities occurring in the caudate nucleus, intermediate levels in the middle and deep layers of the cerebral cortex and lower levels in the dentate gyrus (Fig. 1A) . As it was difficult to visualize specific [ 3 H]-A349821 binding in the dentate gyrus at the lower radioligand concentrations used in the initial saturation of binding study, we used measurements of specific [ 3 H]-A349821 binding in the medial frontal cortex to characterize the binding reaction (Fig. 1B,C) (Fig. 1C) . We next examined whether PAE elevated the density of histamine H 3 receptors in the dentate gyrus, as well as medial frontal cortex and the caudate nucleus. The quantity of donated radioligand remaining was not sufficient to conduct a full saturation of specific [ 3 H]-A349821 receptor binding study in control and PAE rats. Thus, sagittal sections from both control and PAE rat offspring were incubated in the presence of either a "near Kd" (9 nM) or a "near-saturating" (33.6 nM) concentration of [ (Fig. 1A) . However, the agonist-stimulated signal coupled with the higher specific activity of In an initial study in control and PAE rats, a near-maximally effective concentration of methimepip (2 lM) was used to measure histamine H 3 agonist-stimulated [ GTPcS binding was highest in medial frontal cortex, followed by intermediate levels in parietal cortex, nucleus accumbens, and caudate nucleus, and lower levels in dentate gyrus, cerebellum, and the superior colliculus and inferior colliculus (Fig. 2B) . In contrast to specific [ A subsequent more detailed agonist dose-response study, focused on the dentate gyrus, revealed that methimepip-stimulated [ 35 S]-GTPcS binding increased above baseline over a roughly 4 orders of magnitude increase in methimepip concentration (Fig. 3) . A 2-way ANOVA revealed significant effects of methimepip, F(1,15) = 90.3, p < 0.001, and prenatal treatment group, F(1,15) = 31.4, p < 0.001, and no interaction between factors. At the apparent near-maximally effective agonist concentration of 5 lM methimepip, [ (A) Representative fEPSP traces evoked by pairs of pulses given at a 40-ms interpulse interval are shown at 0 and 3 lM methimepip for control and PAE rats. (B) Effect of PAE on methimepip inhibition of first-pulse fEPSP amplitude responses. Data bars represent the mean AE SEM first-pulse fEPSP amplitude, expressed as percent of saccharin control baseline responses, from 7 pairs of control and PAE rats. Asterisks denote significantly greater inhibition in PAE rats compared to controls (*p < 0.05). (C) Effects of PAE on methimepip enhancement of the paired-pulse ratio. Data bars represent the mean AE SEM paired-pulse ratio, expressed as the second fEPSP pulse amplitude/first fEPSP pulse amplitude, in 7 pairs of control and PAE rats. Asterisks denote a significantly higher PPR, reflecting a lower probability of glutamate release in PAE rats compared to controls (*p < 0.05). (Fig. 3) . A kinetic analysis of the H 3 agonist dose-response data using LIGAND indicated the presence of 2 agonist-sensitive subpopulations of histamine H 3 receptors (Table 3) . In control rats, the higher (K D 1) and lower (K D 2) affinity H 3 receptor subpopulations each accounted for about one-half of the maximal agonist response, with apparent affinity constants of 0.868 and 422 nM, respectively. In PAE rats, the apparent affinity constants were not significantly different from controls nor was the agonist response to the higher affinity receptor population (Re max 1) different. In contrast, the agonist response at the lower affinity population (Re max 2) was significantly greater in PAE rats compared to controls ( Table 3) .
Effects of Methimepip on Glutamatergic Synaptic Transmission in the Dentate Gyrus
In the final set of experiments, we examined whether there was a physiological correlate to the observed PAE-induced increase in H 3 receptor-effector coupling by conducting extracellular recording of granule cell responses to perforant path-evoked stimulation in slices of dentate gyrus. The recordings were performed in the same region of the dentate gyrus stratum moleculare as studied in the radiohistochemical experiments. Increased electrical stimulation of perforant path fibers in the medial layer of the dentate gyrus stratum moleculare resulted in increased fEPSP responses. However, as was observed previously in in vivo electrophysiological studies in control and PAE rats , PAE did not affect input/output responses dentate granule cells in slices (Fig. 4) .
The effects of methimepip and PAE on electrically evoked fEPSP responses and on the PPR measure of glutamate release are depicted in Fig. 5 . Perfusing control slices with increasing concentrations of methimepip (0.3 ro 3 lM) resulted in a modest decrease in fEPSP responses (Fig. 5B) . In contrast, methimepip produced greater inhibition of fEPSP responses in slices from PAE rat offspring. A 2-way ANOVA indicated significant effects of both methimepip, F (1,3) = 8.08, p < 0.001, and prenatal treatment group, F (1,3) = 5.91, p = 0.019, but no significant interaction between factors. Post hoc analysis revealed a significant difference between the control and PAE group only at the 3 lM concentration of methimepip (Fig. 5B) . Methimepip also dose dependently increased the PPR measure of glutamate release to a greater extent in PAE rats compared to controls (Fig. 5C ). Increasing the PPR is an index of a reduction in glutamate release probability. A 2-way ANOVA indicated significant effects of both methimepip, F(1,3) = 16.3, p < 0.001, and prenatal treatment group, F(1,3) = 10.4, p < 0.001, but no significant interaction between factors. A post hoc analysis revealed a significant difference between the control and PAE group at both the 1 and 3 lM concentrations of methimepip (Fig. 5C ).
DISCUSSION
The salient findings in this study are that prenatal exposure to moderate levels of alcohol increased methimepip-stimulated H 3 receptor-effector coupling in dentate gyrus as well as enhanced methimepip's inhibitory effects on firstpulse fEPSPs and glutamate release. Further, the concentrations of methimepip that reduced fEPSP responses (Fig. 5B ) and heightened the PPR (Fig. 5C) were similar to the methimepip concentrations that enhanced [ 35 S]-GTPcS binding (Fig. 3 ) measured in the same region within the superior blade of the dentate gyrus where the electrophysiological studies were performed. That methimepip-stimulated [ 35 S]-GTPcS binding was also elevated in a variety of cortical regions, and cerebellum of PAE rats compared to control (Fig. 2B) suggests that PAE-induced elevation in histamine H 3 receptor-mediated inhibition of glutamatergic neurotransmission may occur across large areas of the higher brain.
The mechanistic basis for elevated H 3 receptor-effector coupling in PAE (Fig. 2B) is currently unknown. Specific Table 2 ), suggesting that the total density of histamine H 3 receptors in PAE rat brain is similar to controls (Table 2 ) and thus not the basis for differential agonist-mediated responses. One possible explanation for heightened H 3 receptor-effector coupling could be a PAE-induced alteration in the differential expression of H 3 receptor isoforms expressed by entorhinal cortical neurons projecting to the dentate gyrus. At least 3 functional isoforms of histamine H 3 receptors are expressed in rats (Morisset et al., 2001) . These isoforms, which originate from alternative splicing of the H 3 receptor gene, differ primarily in the length of the amino acid sequence within the third cytoplasmic loop of this transmembrane receptor protein. The truncated isoforms, identified in rat as the rH 3B and rH 3C isoforms, exhibit higher agonist affinity and lower intrinsic activity in comparison with the longer rH 3A isoform, which has lower agonist affinity and higher intrinsic activity (Bongers et al., 2007; Drutel et al., 2001) . One reasoned speculation is that PAE may have shifted the predominant H 3 receptor isoform expressed in entorhinal cortical neurons from the higher affinity less intrinsically active rH 3B or rH 3C isoforms to the lower affinity more intrinsically active rH 3A isoform. Whereas there are, currently, no receptor subtype-selective H 3 receptor drugs or antibodies to directly examine this question, 1 alternative approach was to conduct a detailed H 3 agonist dose-response response study in control and PAE rats. While there was a small shift in the proportional agonist response between the higher and lower affinity receptor populations in PAE rats compared to controls (Table 3) , which is consistent with speculation about a differential shift in the expression of H 3 receptor isoforms, it is unclear whether a small shift in the differential expression of H 3 receptor isoforms alone could account for the differential agonist responses (Figs 3 and 5B,C) observed in PAE rats.
One mechanism for increased intrinsic activity of the receptor-effector response could be an increase in the quantity of G i/o protein levels in the perforant path nerve terminals. However, the observation that basal [ 35 S]-GTPcS binding was not different between prenatal treatment groups (data not shown) does not support this idea. Another explanation could relate to the involvement of intracellular mechanisms that regulate G protein coupling of metabotropic receptors to their effector mechanisms. While virtually nothing is known about these regulatory processes with respect to H 3 receptors, there is evidence that various protein kinases and other factors regulate the coupling of another G i/o protein-coupled receptor, namely the mGluR 7 receptor (Sorensen et al., 2002) , which also regulates the release of glutamate (Pelkey et al., 2005; Zhang et al., 2008) . This is an intriguing prospect relative to the differential receptor-effector coupling response in PAE rats given that some of these regulatory mechanisms target the third cytoplasmic loop of the mGluR 7 receptor.
Whatever the mechanistic basis for elevated H 3 receptoreffector coupling in PAE rats, this alteration provides 1 explanation for methimepip's greater inhibitory effect on fEPSP responses and glutamate release (Fig. 5B,C ) in PAE rats. The possible mechanisms by which histamine H 3 receptors inhibit glutamate release can be inferred based on evidence from studies of other presynaptic G i/o protein-coupled receptors (reviewed by Betke et al., 2012) . Upon activation, these G proteins dissociate into G i/o a and bc-subunits. The activated G i/o a-subunit inhibits adenylyl-cyclase activity, leading to reduced cAMP levels and, consequentially, reduced protein kinase A (PKA) activity. As presynaptic voltage-gated calcium channels are a substrate for PKA, reduced phosphorylation of these channels could decrease neurotransmitter release. Additionally, the activated G i /G o bc-subunit directly inhibits voltage-gated calcium channels at axon terminals as well as soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein, leading to reduced synaptic vesicle exocytosis, further contributing to decreased neurotransmitter release. Histamine inhibits dentate gyrus granule cell excitability and glutamate release, probably by a direct blockade of voltage-gated calcium channels by bc-subunits of G i/o protein (Brown and Haas, 1999; Brown and Reymann, 1996) . Here, it remains to be investigated whether or not PAE increases H 3 receptor-mediated inhibition of adenylate cyclase and/or reduces voltage-gated calcium channel conductance as potential mechanisms for the observed differential effect on glutamate release.
Given prior studies demonstrating the inhibitory effects of H 3 receptor agonists on glutamate release and dentate granule cell responses both in vitro (Brown and Reymann, 1996) and in vivo (Manahan-Vaughan et al., 1998; Varaschin et al., 2014) , one somewhat unexpected result in the present study was the observation that methimepip produced only modest inhibition of fEPSP responses or glutamate release in control offspring (Fig. 5B,C) . Differences in slice electrophysiological approaches between laboratories may, in part, account for this apparent discrepancy. In the present study, 1 putative explanation for the different degrees of responses to methimepip by 12-lm-thick sections used in radiohistochemical studies compared to 400-lmthick slices used in physiological studies may be that higher agonist concentrations are required to penetrate slices to elicit responses of similar magnitude. Thus, it is possible that a greater degree of methimepip inhibition of fEPSP responses and glutamate release in control slices may have been observed had higher agonist concentrations been employed in this study. Nevertheless, the results indicate that PAE rats were more responsive to the inhibitory effects of methimepip than controls.
In summary, these in vitro studies provide the first report of a heightened histamine H 3 receptor-mediated receptor-effector coupling associated with an inhibition of glutamate release from entorhinal cortical projections to the dorsal dentate gyrus of PAE rats compared to control offspring. This elevated inhibitory drive provides 1 mechanistic explanation for our prior observations of deficits in dentate gyrus LTP . However, given the complexity of the intrinsic and extrinsic regulation of dentate granule cell responsiveness, studies employing microinjections of a histamine H 3 inverse agonist directly into the dentate gyrus will be required to further substantiate this interpretation. In addition, other putative mechanisms of H 3 receptor inverse agonist/antagonist action in the dentate gyrus remain to be investigated. For example, the inhibition of H 3 receptors on cholinergic nerve terminals facilitates acetylcholine release (Fox et al., 2005) , which, in turn, could facilitate glutamatergic neurotransmission. In addition, H 3 receptor antagonist-mediated inhibition of H 3 autoreceptors located on histaminergic nerve terminals promotes histamine release (Arrang et al., 1983) , which may facilitate excitation of glutamatergic neurons mediated via histamine postsynaptic H 1 and H 2 receptors (Haas, 1984; ManahanVaughan et al., 1998; Selbach et al., 1997) . Further, histamine has been reported to have positive allosteric effects at the spermidine site on NMDA receptors (i.e., Bekkers, 1993; Vorobjev et al., 1993) . The extent to which each of these other mechanisms of H 3 receptor inverse agonist/antagonist action may have contributed to an amelioration of a synaptic plasticity deficit in PAE offspring is not known, but it is likely that the manner by which H 3 receptor inverse agonists/antagonists enhance synaptic transmission at glutamatergic synapses in the central nervous system is complex, may be dose dependent, and may also depend on level of arousal (Luo and Leung, 2010) .
